Ellipses Pharma
6 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| A Study to Evaluate the Safety and Tolerability of EP0089 (NCT07030478) | Ellipses Pharma | 2025-09-01 |
| EP0057 in Combination With Olaparib in Relapsed Advanced Gastric Cancer and Small Cell Lung Cancer (NCT05411679) | Ellipses Pharma | 2023-04-01 |
| Phase 1/2 Study to Evaluate EP0062 as Monotherapy and in Combination in Patients With Advanced or Metastatic AR+/HER-2-/ER+ Breast Cancer (NCT05573126) | Ellipses Pharma | 2023-01-11 |
| A Study of EP0031 (Lunbotinib) in Patients With Advanced RET-altered Malignancies (NCT05443126) | Ellipses Pharma | 2022-09-30 |
| EP0057 in Combination With Olaparib in Advanced Ovarian Cancer (NCT04669002) | Ellipses Pharma | 2020-12-14 |
| Study to Evaluate the Safety and Tolerability of EP0042 (NCT04581512) | Ellipses Pharma | 2020-11-02 |
Track Ellipses Pharma automatically
Every clearance here is in the API, with alerts when new ones post.